Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on Repligen, Raises Price Target to $260

Keybanc analyst Paul Knight maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $245 to $260.

byBenzinga Newsdesk

August 3, 2022

1 minute read

Keybanc analyst Paul Knight maintains Repligen (NASDAQ:RGEN) with a Overweight and raises the price target from $245 to $260.

Worthington Industries Stock Plunges On Q3 Results, Weak Margins

By Akanksha Bakshi

Today, 10:39 PM

Worthington Industries, Inc. (NYSE:WOR) reported third-quarter FY22 net sales growth of 81.6% year-over-year to $1.38 billion, beating the consensus of…

WOR

Alibaba Up Over 2%, Nio Down 3%: Hong Kong Stocks Mixed As Varying Voices From Fed Cool Rally Down

By Bhavik Nair

Today, 10:39 PM

Hong Kong stocks traded mixed on Tuesday morning, with the benchmark Hang Seng Index trading 1.87% higher, while some electric-vehicle stocks took a hit. Different voices from the U.S.

BABA